Trials / Unknown
UnknownNCT05944185
Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- Sponsor
- Shanghai Cell Therapy Group Co.,Ltd · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
An open, multicenter, phase I/II study to evaluate the safety, tolerability, and effectiveness of αPD1-MSLN-CAR T cells in patients With MSLN-positive advanced solid tumors
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | αPD1-MSLN-CAR T Cells | αPD1-MSLN-CAR T Cells |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2024-09-01
- Completion
- 2025-09-01
- First posted
- 2023-07-13
- Last updated
- 2023-07-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05944185. Inclusion in this directory is not an endorsement.